Applied Dna Sciences (NASDAQ:BNBX) Releases Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) issued its quarterly earnings data on Thursday. The company reported ($2.08) EPS for the quarter, Zacks reports. Applied Dna Sciences had a negative return on equity of 191.67% and a negative net margin of 399.91%.

Applied Dna Sciences Price Performance

NASDAQ:BNBX traded down $0.06 on Thursday, reaching $0.80. The stock had a trading volume of 47,820 shares, compared to its average volume of 211,622. The stock has a market cap of $3.49 million, a P/E ratio of 0.00 and a beta of 0.57. Applied Dna Sciences has a 12-month low of $0.79 and a 12-month high of $142.20.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings began coverage on Applied Dna Sciences in a report on Monday, January 26th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat, Applied Dna Sciences has a consensus rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.